PUREfi Wealth
AZN icon

PUREfi Wealth’s AstraZeneca AZN Stock Holding History

PUREfi Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$293K Buy
1,816
+28
+2% +$4.67K 0.14% 180
2026
Q2 		$339K Buy
1,788
+510
+40% +$95.9K 0.19% 142
2026
Q1 		$252K Buy
+1,278
New +$246K 0.17% 159

Other funds holding AZN

Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

PUREfi Wealth's AZN Position: Q3 2026 in Review

PUREfi Wealth increased its AstraZeneca (AZN) stake by 1.6% in Q3 2026, buying an estimated $4.67K and bringing the position to 1,816 shares worth $293K. The position accounts for 0.14% of the portfolio, ranked #180.

PUREfi Wealth first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $339K in Q2 2026. 677 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • PUREfi Wealth held 1,816 shares of AstraZeneca worth $293K as of Q3 2026.
  • PUREfi Wealth bought 28 AstraZeneca shares in Q3 2026, an estimated $4.67K.
  • AstraZeneca made up 0.14% of PUREfi Wealth's portfolio in Q3 2026, its #180 holding.
  • PUREfi Wealth first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • PUREfi Wealth's AstraZeneca position peaked at $339K in Q2 2026.
  • 677 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on PUREfi Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.